文献速递认知障碍与痴呆

小胶质细胞反应性与突触前损失相关,且独立于β-淀粉样蛋白和tau蛋白

Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau.
PubMed 文献 · Ann Neurol · 2024-02-14

该研究纳入663名参与者,其中254人有纵向脑脊液生物标志物数据,另以65例中国衰老队列脑脊液样本验证,采用多变量回归分析。结果显示较高的Aβ负荷可能减弱p-Tau相关的微胶质反应,而TREM2相关微胶质反应性独立于Aβ和p-Tau与GAP-43相关的突触前损失相关。

要点

  • 较高的Aβ负荷与减弱脑脊液p-Tau181对微胶质生物标志物升高的效应相关。
  • 脑脊液sTREM2升高而非PGRN升高,独立于Aβ和p-Tau,与脑脊液GAP-43升高及更快的GAP-43增加速率相关。
  • 微胶质反应性在AD中可能具有双重作用。

核心结论

  • 较高的Aβ负荷可能减弱p-Tau相关的微胶质反应,TREM2相关的微胶质反应性可能独立地与GAP-43相关的突触前损失相关。
  • 该研究突显了微胶质反应性在AD和其他神经退行性疾病中的双重作用。

研究设计与样本

  • 研究纳入663名具有基线Aβ PET和脑脊液生物标志物数据的参与者,其中254人有同期纵向脑脊液生物标志物数据。
  • 另分析一个中国衰老队列的独立脑脊液样本(n=65)作为验证。
  • 采用多变量回归分析研究脑脊液微胶质生物标志物与Aβ PET、脑脊液p-Tau181和脑脊液GAP-43的横断面和纵向关联。

主要发现

  • 较高的基线脑脊液微胶质生物标志物水平与更快的脑脊液sTREM2增加速率和更快的脑脊液PGRN下降速率相关。
  • 脑脊液p-Tau181升高与较高的脑脊液微胶质生物标志物水平和更快的脑脊液sTREM2增加速率及更快的脑脊液PGRN下降速率相关。
  • 在两个队列中,较高的Aβ负荷与减弱的脑脊液p-Tau181对脑脊液微胶质生物标志物升高的效应相关。
  • 独立于Aβ PET和脑脊液p-Tau181病理,较高的脑脊液sTREM2水平而非脑脊液PGRN水平与脑脊液GAP-43水平升高及更快的脑脊液GAP-43增加速率相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Triggering receptor expressed on myeloid cells-2 (TREM2) and progranulin (PGRN) are critical regulators of microglia activation and can be detected in cerebrospinal fluid (CSF). However, whether microglial reactivity is detrimental or neuroprotective for Alzheimer disease (AD) is still debatable. METHODS: We identified 663 participants with baseline β-amyloid (Aβ) positron emission tomography (PET) and CSF biomarker data, including phosphorylated tau181 (p-Tau181), soluble TREM2 (sTREM2), PGRN, and growth-associated protein-43 (GAP-43). Among them, 254 participants had concurrent longitudinal CSF biomarkers. We used multivariate regression analysis to study the associations of CSF microglial biomarkers with Aβ PET, CSF p-Tau181, and CSF GAP-43 cross-sectionally and longitudinally. A Chinese aging cohort's independent CSF samples (n = 65) were analyzed as a validation. RESULTS: Higher baseline levels of CSF microglial biomarkers were related to faster rates of CSF sTREM2 increase and CSF PGRN decrease. Elevated CSF p-Tau181 was associated with higher levels of CSF microglial biomarkers and faster rates of CSF sTREM2 increase and CSF PGRN decrease. In both cohorts, higher Aβ burden was associated with attenuated CSF p-Tau181 effects on CSF microglial biomarker increases. Independent of Aβ PET and CSF p-Tau181 pathologies, higher levels of CSF sTREM2 but not CSF PGRN were related to elevated CSF GAP-43 levels and faster rates of CSF GAP-43 increase. INTERPRETATION: These findings suggest that higher Aβ burden may attenuate the p-Tau-associated microglial responses, and TREM2-related microglial reactivity may independently correlate with GAP-43-related presynaptic loss. This study highlights the two-edged role of microglial reactivity in AD and other neurodegenerative diseases. ANN NEUROL 2024;95:917-928.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Lan G, Chen X, Yang J, et al. Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau. Ann Neurol. 2024. PMID: 38356322. doi:10.1002/ana.26885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。